BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31523839)

  • 41. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
    Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr WR; Kopp C; Sillaber C; Semper H; Horny HP; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
    Wien Klin Wochenschr; 1998 Feb; 110(3):79-88. PubMed ID: 9553202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.
    Grimwade LF; Happerfield L; Tristram C; McIntosh G; Rees M; Bench AJ; Boyd EM; Hall M; Quinn A; Piggott N; Scorer P; Scott MA; Erber WN
    Br J Haematol; 2009 Nov; 147(4):495-506. PubMed ID: 19747364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations.
    Broesby-Olsen S; Kristensen TK; Møller MB; Bindslev-Jensen C; Vestergaard H;
    J Allergy Clin Immunol; 2012 Sep; 130(3):806-8. PubMed ID: 22608575
    [No Abstract]   [Full Text] [Related]  

  • 44. Systemic mastocytosis associated with acute myeloid leukaemia.
    Kim MJ; Kim MK; Kim YK; Gu MJ
    Pathology; 2017 Oct; 49(6):652-654. PubMed ID: 28826833
    [No Abstract]   [Full Text] [Related]  

  • 45. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.
    Wang SA; Hasserjian RP; Loew JM; Sechman EV; Jones D; Hao S; Liu Q; Zhao W; Mehdi M; Galili N; Woda B; Raza A
    Leukemia; 2006 Sep; 20(9):1641-4. PubMed ID: 16871284
    [No Abstract]   [Full Text] [Related]  

  • 46. Kit Mutations: New Insights and Diagnostic Value.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.
    Steensma DP
    J Mol Diagn; 2006 Sep; 8(4):397-411; quiz 526. PubMed ID: 16931578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
    Atallah E; Nussenzveig R; Yin CC; Bueso-Ramos C; Tam C; Manshouri T; Pierce S; Kantarjian H; Verstovsek S
    Leukemia; 2008 Jun; 22(6):1295-8. PubMed ID: 18059483
    [No Abstract]   [Full Text] [Related]  

  • 49. KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.
    Garcia-Montero AC; Jara-Acevedo M; Alvarez-Twose I; Teodosio C; Sanchez-Muñoz L; Muñiz C; Muñoz-Gonzalez JI; Mayado A; Matito A; Caldas C; Morgado JM; Escribano L; Orfao A
    Blood; 2016 Feb; 127(6):761-8. PubMed ID: 26622064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Schmitt-Graeff AH; Teo SS; Olschewski M; Schaub F; Haxelmans S; Kirn A; Reinecke P; Germing U; Skoda RC
    Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spontaneous remission of anemia associated with a myelodysplastic syndrome with disease evolution into a myeloproliferative state.
    Tefferi A; Inwards DJ; Hoyer JD
    Acta Haematol; 1999 Mar; 101(1):50-2. PubMed ID: 10085439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders.
    Cross NCP; Godfrey AL; Cargo C; Garg M; Mead AJ;
    Br J Haematol; 2021 Nov; 195(3):338-351. PubMed ID: 34409596
    [No Abstract]   [Full Text] [Related]  

  • 53. Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis with co-mutated JAK2 and SF3B1.
    Reinig EF; He R
    Blood; 2017 Feb; 129(5):656. PubMed ID: 28153838
    [No Abstract]   [Full Text] [Related]  

  • 54. Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity.
    El Hussein S; Hu S; Fang H; Garces S; Muzzafar T; Wang SA; Medeiros LJ; Bueso-Ramos C; Jelloul FZ
    Leuk Lymphoma; 2022 Jan; 63(1):235-238. PubMed ID: 34510998
    [No Abstract]   [Full Text] [Related]  

  • 55. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.
    Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
    Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A
    Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extramedullary myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with ring sideroblasts and thrombocytosis.
    Kerneves P; Cornet E; Paubelle E
    Int J Lab Hematol; 2021 Oct; 43(5):890-891. PubMed ID: 33586865
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic mastocytosis with an associated non mast cell lineage clonal hematological disease in a child.
    Sharma S; Harbhajanka A; Jain A; Seth A
    Indian J Pathol Microbiol; 2011; 54(4):854-6. PubMed ID: 22234140
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of gDNA-based versus mRNA-based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Br J Haematol; 2017 Jul; 178(2):330-332. PubMed ID: 27196380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.